LATEST NEWS
More
FDA approves targeted therapy for first-line treatment of patients with a...
The U.S. Food and Drug Administration today approved Iressa (gefitinib) for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose...
Routine Dental Trip Leaves Patient With a Rare Infection
Sugar seems to have developed a reputation as the big bad wolf in relation to health. We have reported on numerous studies associating sugar...
SPECIALITTY AREAS
- All
- ASCO 2016
- Ash 2014
- brain tumor
- Breast cancer
- Cancer
- Chemotherapy
- CLL
- Conferences
- ECCO 2017
- Embedded Technology
- EONS 10
- ESMO
- Featured
- Imaging Technology
- Leukaemia
- Lung cancer
- Media
- Medical Devices
- Melanoma
- Metastatic
- Neutropenia
- Oncology
- Oncology Nursing
- Oropharyngeal cancer
- Ovarian cancer
- Pharmacy
- Prevention
- Prostate cancer
- Public Health
- Radio therapy
- Rare Tumors
- Rectal Cancer
- Research
- Sarcoma
- Specialities
- T cell
- Thyroid cancer
- vaccine
- Videos
- Viruses & Bacteria
- Wireless Technology
More
LATEST ARTICLES
- Advertisement -
